| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041751 |
| Receipt No. | R000047653 |
| Scientific Title | Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake |
| Date of disclosure of the study information | 2021/12/18 |
| Last modified on | 2021/03/31 (Ver. 4) |
| Basic information | ||
| Public title | Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake | |
| Acronym | Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake | |
| Scientific Title | Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake | |
| Scientific Title:Acronym | Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of subject food intake for 8 consecutive weeks on the subjective evaluation of fatigue, vitality, and sleep, using placebo as a control. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | POMS2 T-score and OSA-MA at before, 4 and 8 weeks |
| Key secondary outcomes | SF36 at before, 4 and 8 weeks and flulike symptoms score during intake period |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of test food daily intake, for 8 weeks | |
| Interventions/Control_2 | Intake of placebo daily intake, for 8 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Men and women between 20 and 64 years of age.
(2) Subjects who feel fatigued and less active (3) Subjects with poor sleep quality |
|||
| Key exclusion criteria | (1) Subjects who regularly use health foods containing the ingredients involved in the test food
(2) Subjects engaged in actions/drugs or health food use to improve fatigue, stress, or sleep. (3) Subjects with a disease undergoing treatment or with a disease determined to be in need of treatment. (4) Subjects who have, have been diagnosed with, or are strongly suspected of having a sleep-related illness. (5) Subjects with a previous diagnosis of chronic fatigue syndrome (6) Subjects who are being treated for or have a history of mental illness, or are suspected to be suffering from one. (7) Seriously ill subjects and subjects with a history of serious illness (8) Subjects with irregular working days (holidays) (9) Subjects whose lives will become irregular more than once during the research period due to day/night shift work or night work, or who are engaged in physical labor such as heavy lifting. (10) Subjects with major life changes planned during the study period. (11) Subjects who have allergic diseases and are constantly taking therapeutic medication. (12) Subjects with diarrhea (13) Subjects with less than 3 bowel movements per week. (14) Subjects who are pregnant or lactating and who plan to become pregnant or breastfeeding during the study period. (15) Subjects at risk of developing allergies in connection with the study. (16) Subjects whose physical measurements, physical examination values, and clinical examination values at the pre-examination are significantly outside the reference range. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kenkoukazoku Co., Ltd. | ||||||
| Division name | None | ||||||
| Zip code | 892-0848 | ||||||
| Address | 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN | ||||||
| TEL | 099-223-5211 | ||||||
| yasushi.nakasone@kenkoukazoku.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kenkoukazoku Co., Ltd. | ||||||
| Division name | None | ||||||
| Zip code | 892-0848 | ||||||
| Address | 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN | ||||||
| TEL | 099-223-5211 | ||||||
| Homepage URL | |||||||
| yasushi.nakasone@kenkoukazoku.co.jp | |||||||
| Sponsor | |
| Institute | TTC Co., Ltd |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kenkoukazoku Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Station Clinic Research Ethics Committee |
| Address | 3-12-8, Takaban, Meguroku, Tokyo |
| Tel | 03-6452-2712 |
| t.saito@ttc-smo.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047653 |